ArticleDisease markers2022

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer.

Ranran Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.